Edition:
United Kingdom

Revenio Group Oyj (REG1V.HE)

REG1V.HE on Helsinki Stock Exchange

15.82EUR
19 Oct 2018
Change (% chg)

€-0.26 (-1.62%)
Prev Close
€16.08
Open
€16.08
Day's High
€16.08
Day's Low
€15.82
Volume
20,542
Avg. Vol
22,083
52-wk High
€16.60
52-wk Low
€11.00

Summary

Name Age Since Current Position

Pekka Ronka

2018 Independent Chairman of the Board

Timo Hilden

57 2017 Chief Executive Officer, Member of the Management Team

Robin Pulkkinen

36 2015 Chief Financial Officer, Member of the Management Team

John Floyd

2016 Chief Executive Officer of Icare USA

Ari Kukkonen

64 2018 Senior Advisor

Tiina Olkkonen

2016 External Communications Specialist, Member of the Management Team, Secretary

Ari Isomaki

50 2016 Icare Finland Ltd Operations Director, Member of the Management Team,

Tomi Karvo

50 2015 Icare Finland's Sales and Marketing Director, Member of the Management Team

Mika Salkola

2018 Revenio Research Oy's R&D Director, Member of the Group Management Team

Heli Valtanen

2018 Icare Finland Ltd's QA Manager, Member of the Group Management Team

Ann-Christine Sundell

53 2016 Director

Kyosti Kakkonen

60 2014 Independent Director

Ari Kohonen

61 2013 Independent Director

Pekka Tammela

56 2018 Independent Director

Biographies

Name Description

Pekka Ronka

Mr. Pekka Ronka has been Independent Chairman of the Board of Revenio Group Oyj since March 20, 2018. He has been Independent Member of the Board of Directors of Revenio Group Oyj since March 20, 2014. Pekka Ronko currently acts as Chairman of the Board of Directors of HLD Healthy Life Devices Oy and Magnasense Technologies Oy. He has previously been, among other, Vice President and General Manager in Thermo Fisher Scientific (1999-2012). Earlier he has held the position of Vice President in Labsystems Oy. He holds a Master of Science degree in Engineering.

Timo Hilden

Mr. Timo Hilden has been appointed Chief Executive Officer of Revenio Group Oyj, effective as of January 1, 2017. He no longer serves as Chief Executive Officer of Icare Finland Ltd's, Segment Director of Revenio Health Tech effective as of January 1, 2017. He has held this position since May 16, 2016. He was Chief Executive Officer of Icare Finland Oy within Revenio Group Oyj from April 9, 2012. He has also been Chief Executive Officer of Revenio Research Oy since December 29, 2014. He has also been Member of the Management Team of the Company since May 22, 2014. Timo Hilden has 30 years of experience in the health technology sector, at Orion Group, Labsystems, Thermo Electron and Thermo Fisher Scientific, holding positions in general management, sales and marketing. In the early 1990s, he was involved in the launch of production and sales companies in Russia and China, later assuming responsibility for production and marketing units in the USA, Mexico and Finland. He was also in charge of product development units in Finland and the United States. Timo was involved in numerous acquisitions while working for Thermo. He was Thermo Fisher Scientific Oy's Managing Director and Director of Global Business for Liquid Handling Instruments. Mr. Hilden holds a Master of Science degree in Economics.

Robin Pulkkinen

Mr. Robin Pulkkinen has been appointed Chief Financial Officer and Member of the Management Team of Revenio Group Oyj, effective as of July 15, 2015. He holds Master of Science degree in Economics. He joins Revenio from the position of Symbio's EMEA area CFO. Prior to Symbio Pulkkinen has held several top management positions in international corporations both in Finland and Canada having solid experience in various roles of financial management.

John Floyd

Ari Kukkonen

Mr. Ari Kukkonen has been appointed Senior Advisor at Revenio Group Oyj effective as of February 1, 2018. He has previously been Revenio Research Ltd, R&D Director and Member of the Management Team at Revenio Group Oyj since June 1, 2016. He was Icare Finland's Research & Development Director and Member of the Management Team at the Company from August 6, 2015 until June 1, 2016. Ari Kukkonen has acted as the R&D Director of Icare Finland since December 2011. Before moving on to Icare Finland, Kukkonen spent several years as Director R&D at Thermo Fisher Scientific, overseeing product development in two business units (Vantaa and Hudson, USA). Kukkonen has broad international expertise in the development of health technology products. He holds Master of Science degree.

Tiina Olkkonen

Ari Isomaki

Tomi Karvo

Mr. Tomi Karvo has been Icare Finland's Sales and Marketing Director, Member of the Management Team at Revenio Group Oyj since August 6, 2015. Tomi Karvo has spent 20 years working in various managerial positions in international business and sales and marketing in the field of health technology. His former employers include Datex-Ohmeda, Spacelabs, Perlos and Medisize. His latest position was that of Hospital Division Director at Serres Oy. He was one of the forerunners who introduced the Medical IT business to Germany and Austria, and has participated in numerous corporate acquisitions while employed by Datex-Ohmeda and Perlos. He holds Master of Science degree and Master of Business Administration degree.

Mika Salkola

Mr. Mika Salkola has been appointed Revenio Research Oy's R&D Director and Member of the Group Management Team at Revenio Group Oyj effective as of February 1, 2018. Mika Salkola has previously worked as R&D Director of Icare Finland since September 2015. Mika has extensive experience in R&D. He has over 20 years of experience in international R&D operations, among others at Thermo Fisher Scientific and Vaisala.

Heli Valtanen

Mr. Heli Valtanen has been appointed Icare Finland Ltd's QA Manager and Member of the Group Management Team at Revenio Group Oyj effective as of February 1, 2018. Heli Valtanen has held the position of QA Manager at Icare Finland since 2010. Previously Heli has worked as QA Manager at Plexpress Oy, as CTO at CTT Cancer Targeting Technologies Ltd and as Research Scientist at University of Helsinki, Haartman Institute.

Ann-Christine Sundell

Ms. Ann-Christine Sundell has been Member of the Board of Directors of Revenio Group Oyj since March 15, 2016. Ann-Christine Sundell currently acts as a Member of the Board in Raisio Oyj, Minerva Foundation for Medical Research, Serres Oy, Zymonostics ApS (Denmark), Oy Medix Ab ja Ledil Oy and as the Chairman of the Board in Medix Biochmica Oy. She has previously been, among other, President, Segment manager and Marketing manager to PerkinElmer during 1999-2010. She holds Master of Science degree.

Kyosti Kakkonen

Mr. Kyosti Kakkonen has been Independent Member of the Board of Directors of Revenio Group Oyj since March 20, 2014. Mr. Kyosti Kakkonen is the founder of Tokmanni Group and has served as CEO in the group for 20 years until 2009. Today Kakkonen acts as CEO in several companies of his own, such as Joensuun Kauppa ja Kone Oy, K2 Invest Oy and Kakkonen-Yhtiot Oy. He holds a Bachelor of Legal Letters degree.

Ari Kohonen

Mr. Ari Kohonen has been Independent Member of the Board of Directors of Revenio Group Oyj since March 21, 2013. He is also Chairman of the Board of Directors of Gerako Oy. His previous positions include several international and investment banking positions at Nordea (1983-2003) and a CEO’s position at Tekla Oyj (2004–2013). He holds a Master of Science degree in Engineering and a Master of Science degree in Economics.

Pekka Tammela

Mr. Pekka Tammela has served as Independent Director of Revenio Group Oyj (formerly known as Done Solutions Oyj) since March 20, 2018. He has previously been Independent Chairman of the Board since March 21, 2013. He has been Member of the Board of Directors of the Company since April 3, 2007. He works as Partner in Pajamaa Partners Oy. He served in different managerial posts from 1999 to 2006, such as Chief Financial Officer in Solteq Oyj and Panostaja Oyj, and Senior Manager in KPMG and PricewaterhouseCoopers. Prior to 1999, he worked as Authorized Public Accountant. He holds a Master of Science degree in Economics.